1.
Deletion of sphingosine kinase 2 attenuates cigarette smoke-mediated chronic obstructive pulmonary disease-like symptoms by reducing lung inflammation. Biomol Biomed [Internet]. 2023 Mar. 16 [cited 2024 Jun. 19];23(2):259–270. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/8034